News

:::
:::
Fucoidan Prevents M2 Macrophage Differentiation and HCT116 Tumor Progression in Mice

Fucoidan Prevents M2 Macrophage Differentiation and HCT116 Tumor Progression in Mice NHRI

A Novel Imaging-guided High-Intensity Focused Ultrasound System for Treatment of Breast Tumors

A Novel Imaging-guided High-Intensity Focused Ultrasound System for Treatment of Breast Tumors

A Culturally Adapted Treatment Program to Help Recovery from Methamphetamine Addiction in Taiwan

A Culturally Adapted Treatment Program to Help Recovery from Methamphetamine Addiction in Taiwan

Reprogramming Inflammatory Tumor Microenvironment Enhances anti-PD-L1 Cancer Immunotherapy by Vascular Normalization

Reprogramming Inflammatory Tumor Microenvironment Enhances anti-PD-L1 Cancer Immunotherapy by Va

A Novel Tumor Suppressor Regulating Prostate Cancer Metastasis: ROR2 receptor

A Novel Tumor Suppressor Regulating Prostate Cancer Metastasis: ROR2 receptor April 16, 2021 Sc

US FDA approves Taiwan-developed anti-cancer drug-delivery system for phase I clinical study

US FDA approves Taiwan-developed anti-cancer drug-delivery system for phase I clinical study March

NHRI scientists harness nanoparticles to improve use of weight loss drug s by reduc ing their side effects

NHRI has established a novel application of MSNs, enhancing the utility and market development of lipase inhibitor-based anti-obesity drugs by reducing their side effects and elevating life quality